By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Government Accountability Office said today that direct-to-consumer genetics companies may be "misleading" consumers about what their services do and engaging in deceptive marketing practices.

Following an investigation it conducted of some of the players in the industry, the GAO said that the tests offered by these types of firms currently "are of little or no use."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.